• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [4 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2019 Agency for Care Effectiveness (ACE) Rifaximin for reducing recurrent episodes of overt hepatic encephalopathy
2015 National Institute for Health and Care Excellence (NICE) Rifaximin for preventing episodes of overt hepatic encephalopathy. NICE technology appraisal guidance 337
2013 NIHR Health Technology Assessment programme The clinical and cost-effectiveness of rifaximin for maintaining remission from episodes of hepatic encephalopathy
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rifaximin (Xifaxanta®)